BioVectra on the Road to BIO: Bridging Microbial Demand with Expanded Capacity

U.S. CDMO Capacity

More Than Capacity: What the Latest U.S. CDMO Expansion Wave Reveals About Specialized Manufacturing Demand

Pharma's Almanac

M&A

Fewer, Bigger, Smarter: How Pharma M&A Evolved in 2025 — and What Comes Next

David Alvaro, Ph.D.

Pharma's Almanac

Market Trends

What economic or market trends are having the biggest impact on CDMO capacity and pipelines in 2025, and what will 2026 bring?

Pharma's Almanac

Cell Therapy

Building a Better Cell Therapy CDMO

Kincell Bio

Biologics

HIPRA Biotech Services' End-to-End Biologics Offering

HIPRA Biotech Services

Biotech

Australia: Life Sciences' New Frontier

Mark W. Womack

BioCina

Sterile

Expanding Sterile Fill-Finish for the Next Era of Biologics

Afton Scientific

Cell Therapy

How Kincell Bio is Supporting Tomorrow's Cell Therapy Innovators

Mark Bamforth

Kincell Bio

Biomanufacturing

Organoids, ADCs, and More on the Horizon at Samsung Biologics

Kevin Sharp

Samsung Biologics

Biomanufacturing

Exploring Australia's Burgeoning Life Sciences Market with BioCina

Mark W. Womack

BioCina

Automation

3P innovation's Unique Automation Solutions

David Johnson

3P innovation